Futuristic Technologies in Lifescience, Health & Wellness Boost Growth Opportunities
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers innovations on AI augmented diagnostics for cancer and infectious diseases. The increase in clinical utility of liquid biopsies and other diagnostic assays, which is driven by AI has been discussed. The TOE issue also highlights developments in enabling technologies for microbiome analysis, and personalized health solutions based on microbiome testing. A few emerging technologies around DNA synthesis, next generation mRNA therapeutics and diagnostics have been highlighted. Few innovations highlight developments in wound healing solutions, which include smart dressings and plant-based solutions.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Take your first step towards achieving growth-centric solutions with our
Growth Pipeline Dialog™. Speak to our industry experts in a complimentary open discussion that will spark innovative thinking and growth opportunities that will benefit your organization.